retatrutide type 2 diabetes trial results π¨ Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and diabetes. π Mean body weight change at 80 weeks: β¬οΈ Weight loss with retatrutide as
Pay in 4 interest-free payments of $7.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 15 - Aug 20




00092-0/asset/68240365-3bb7-461d-91f9-d644c6b9c749/main.assets/gr3.jpg)






















